Henry Kaplan - Dissemin

All papers authored by Henry Kaplan

This paper was not found in any repository, but could be made available legally by the author.

2024 Henry G. Kaplan

, Alexa K. Dowdell, Anna B. Berry, Racheli Ben Shimol, Fred L. Robinson, Christopher A. Carney, Brian D. Piening

Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Supplementary Methods S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Supplementary Table S4 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Supplementary Table S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Supplementary Table S2 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Supplementary Table S3 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Supplementary Figure S1 from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

Kathy S. Albain, Christina Yau

, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M. Wallace, Henry Kaplan

, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D. Elias, Amy S. Clark and 34 other authors

Data from Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

2023 Kathy S. Albain

, Christina Yau

, Emanuel F. Petricoin

, Denise M. Wolf

, Julie E. Lang

, A. Jo Chien

, Tufia Haddad

, Andres Forero-Torres

, Anne M. Wallace

, Henry Kaplan

, Lajos Pusztai

, David Euhus

, Rita Nanda

, Anthony D. Elias

, Amy S. Clark

and 34 other authors

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Upload

This paper is made freely available by the publisher.

Henry G. Kaplan

, Somasundaram Subramaniam, Eric Vallières, Todd Barnett

Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment

Download from doi.org

2022 Henry G. Kaplan

, Ruyun Jin, Carlo B. Bifulco, James M. Scanlan, David R. Corwin

PCM1-JAK2Fusion Tyrosine Kinase Gene-Related Neoplasia: A Systematic Review of the Clinical Literature

Download from doi.org

2021 Yonghou Jiang, Fergal Duffy, Jennifer Hadlock

, Andrew Raappana, Sheila Styrchak, Ingrid Beck, Fred D. Mast, Leslie R. Miller, William Chour, John Houck, Blair Armistead

, Venkata R. Duvvuri

, Winnie Yeung, Micaela Haglund, Whitney E. Harrington

and 14 other authors

Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection

Download from doi.org

Henry G. Kaplan

, Carlo B. Bifulco, Ruyun Jin, James M. Scanlan, David Corwin

Treatment of PCM1-JAK2 fusion tyrosine kinase gene-related acute lymphoblastic leukemia with stem cell transplantation

Download from doi.org

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Henry Kaplan